Belzutifan (WELIREG) 40 MG

Ended Awarded

Contract number
36C24525N0383
Awardee
Awarding agency
Obligated
$10,105

Award facts

Contract value 100% obligated
$10,105.41 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Carrollton, TX 75010, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5, a civilian agency under the Department of Veterans Affairs, to Insmed Inc. for the drug BELZUTIFAN (WELIREG) 40 MG. The contract has a ceiling value of $10,105.41 and a completion date of February 17, 2025. Insmed Inc. is a global biopharmaceutical company that provides pharmaceuticals and drugs to the VA, including the antibiotic amikacin and the drug ARIKAYCE for the treatment of nontuberculous mycobacterial lung infections. This contract is not designated as a set-aside.

Quick answers

Who was awarded contract 36C24525N0383?

36C24525N0383 was awarded to Insmed Incorporated by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 13, 2025.

How much is contract 36C24525N0383 worth?

The government has obligated $10,105 on 36C24525N0383.

Is contract 36C24525N0383 an order under another contract?

Yes. 36C24525N0383 is a delivery order under 36F79724D0119, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0383 competed?

The extent of competition for 36C24525N0383 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award